Healthcare Global Enterprises Ltd
NSE: HCG BSE: 539787
₹585.80
(0.58%)
Tue, 13 Oct 2026, 07:33 pm
Market Cap (in Cr)8798.38
PE Ratio375.39
Dividend0
Health Services
Hospital/Nursing Management
24.5KCompany History
1998
- The Company was originally incorporated as Curie Centre of Oncology Private Limited.
2005
- The name of the Company was changed to HealthCare Global Enterprises Private Limited.
- The Company entered into the clinical laboratory business through acquisition of Triesta Sciences Inc. and Triesta Sciences (India) Private Limited.
2006
- India Development Fund made its first investment of 500 million in the Company.
- BMORCL became the Subsidiary.
- The Company was converted into a public limited company.
- The name of the Company was changed to HealthCare Global Enterprises Limited.
2007
- HCG Medi-Surge became the Subsidiary.
- Evolvence made its first investment of 225 million in the Company.
2008
- NTICPL made its first investment of 400 million in the Company.
2009
- Amalgamation of Triesta Sciences (India) Private Limited and Triesta Sciences Inc. with the Company.
2010
- IL&FS Trust Company Limited a/c MPEF made its first investment of 312 million in the Company.
2011
- Amalgamation of BMORCL with the Company.
- PIOF became a Shareholder by purchasing shares from NTICPL.
2013
- V-Sciences made its first investment of `600 million in the Company.
- The Company entered into the fertility business through acquisition of 50.10% stake in BACC Healthcare.
2014
- Demerger of multispecialty division from HCG Medi-Surge and vesting of the same with the Company.
2015
- HCG Regency became the Subsidiary.
- Amalgamation of HCG Vijay with the Company.
- HCG was recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India for its in-house research and development activities.
- Milann was recognised as the ‘Emerging IVF Service Provider Company of the Year’ at Frost and Sullivan 7th Annual Indian Healthcare Excellence Awards.
2016
- The Company entered into a Joint Venture Agreement with HCG Regency Oncology Healthcare Pvt. Ltd.
- HCG Launches Advanced Comprehensive Cancer Centre in Baroda.
- Launch of HCG Vizag.
- HCG inaugurates TomoTherapy at its Centre of Excellence.
2017
- HCG The Specialist in Cancer Care was presented with the prestigious title of the ‘Best Medical Tourism Centre of Gujarat’ during the Tourism Awards 2017 event.
2018
- Healthcare Global Enterprises Limited approved the Scheme of Amalgamation of DKR with BACC.
- HCG Hospitals, Bhavnagar was recognised as the ‘Best Multispeciality Hospital’ in Bhavnagar by Saurashtra Samachar.
- HCG Cancer Centre, Ahmedabad was awarded as the ‘Best Cancer Hospital’ by DivyaBhaskar.
2019
- Milann was honoured with The National Icon Award 2018-19 for being ‘India’s Most Trusted IVF Centre’.
2020
- HealthCare Global Enterprises Ltd was recognised for its efficient COVID management initiatives during the 6th India Health and Wealth Awards.
- HCG Hospitals, Ahmedabad was honoured with the ‘Silver Award’ under the COVID Care Brand category during the 6th India Health and Wealth Awards.
2021
- Three centres from the HCG network bagged 1st, 3rd and 6th positions under the National Single Speciality – Oncology category in the Times Health’s All India Critical Care Hospital Ranking Survey 2021.
- Milann was recognised as ‘The Best Fertility and IVF Chain in India’ by ET Healthcare Brands.
- HCG Cancer Centre, Ahmedabad, was honoured with the Times Healthcare Leaders Ahmedabad 2021 Awards for ‘Excellence in Oncology’ and ‘Excellence in Innovative Technology’.
- HCG Cancer Centre, Ahmedabad, was ranked amongst the World’s Best Hospitals 2021 by Newsweek Magazine.
2023
- HCG Cancer Hospital collaborated with Intuitive to deepen accessibility of Robotic-Assisted Surgery across India.
- HealthCare Global Enterprises Limited became India's first mercury-free cancer care chain of hospitals.
2024
- The Company completed the acquisition of shares of Vizag Hospital and Cancer Research Centre Private Limited.
- Healthcare Global Enterprises Ltd partnered with Trucan Diagnostics to pioneer new diagnostic tests for treatment response prediction and monitoring in cancer patients.
- HCG expanded with two new state-of-the-art cancer care centres in Bengaluru.
- HCG was recognized as the Champion of India 2024 at the prestigious Dun & Bradstreet 'ESG Leadership Summit 2024'
